Wintermute has completed its first over-the-counter (OTC) options trade linked to SPCX, which the firm described as SpaceX’s ticker following a potential Nasdaq listing.
The update was shared by Wintermute through a post on X, marking another milestone in the company's expansion of institutional trading services.
The latest transaction follows a previous achievement by Wintermute’s OTC desk, which completed its first single-name stock contract-for-difference (CFD) trade using SpaceX (SPCX) as the underlying asset. The development reflects growing interest from institutional investors seeking exposure to private-market companies through derivative products.
OTC options are privately negotiated contracts that enable counterparties to gain exposure to the price movements of an underlying asset without directly owning it. Such instruments are commonly used for hedging, risk management, and strategic trading purposes.
By executing its first SPCX-linked OTC options trade, Wintermute continues to broaden its range of institutional offerings while bridging traditional financial markets and digital asset infrastructure.
The move also highlights increasing demand for structured products tied to prominent private companies. Although SpaceX remains privately held, derivative instruments such as CFDs and options are creating alternative ways for eligible investors to gain economic exposure to the company's valuation.
The completion of this trade represents another step in the evolution of institutional market products, as firms continue developing innovative solutions to meet growing investor demand for access to high-profile private assets.